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Purpose: The aims of this study were to present the ultrasonographic (US) features of metastatic 
renal cell carcinoma (RCC) in the thyroid gland and to evaluate the diagnostic utility of fine-
needle aspiration (FNA) and core needle biopsy (CNB).
Methods: Eight patients with nine metastatic RCC nodules in the thyroid glands who were 
treated from January 2002 to March 2015 in a single tertiary hospital were consecutively 
selected and retrospectively reviewed. US features and clinical history were obtained from the 
institution’s medical database. FNA was performed nine times on eight nodules and CNB was 
performed six times on six nodules. The diagnostic utility of FNA and CNB was evaluated.
Results: All nine nodules showed mass formation without diffuse thyroid involvement. On 
ultrasonography, metastatic RCC nodules were solid (100%), hypoechoic (100%), and oval-
shaped nodules with a well-defined smooth margin (88.9%) and increased vascularity (100%, 
with 55% showing extensive vascularity). No calcifications were noted in any nodules. Lymph 
node metastasis and direct extension to nearby structures beyond the thyroid gland were not 
found. One FNA (11%) was able to confirm metastatic RCC, whereas all six CNBs confirmed 
metastatic RCC.
Conclusion: Metastatic RCC appears as oval-shaped hypoechoic solid nodules with well-defined 
smooth margins, no calcifications, and increased vascularity on ultrasonography. Characteristic 
US features along with a previous history of RCC should raise clinical suspicion, and CNB should 
be performed to make an accurate diagnosis.
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Introduction
Most malignant thyroid nodules are primary malignancies, and 
papillary carcinoma is the most common subtype [1]. Thyroid 
metastasis is relatively uncommon, and usually originates from 
renal cell carcinoma (RCC), lung cancer, or breast cancer; the 
incidence of thyroid metastasis has been reported to range from 
0.1% to 6% of all thyroid malignancies depending on the study 
design [1-5]. Ultrasonography is commonly performed to detect 
and differentiate thyroid nodules, and the ultrasonographic (US) 
features for metastatic thyroid carcinoma include nonspecific 
findings such as hypoechogenicity, noncircumscribed margins, and 
increased vascularity [1-4,6,7]. RCC is the most common metastatic 
malignancy found in the thyroid glands, accounting for up to 48.1% 
of all metastatic malignancies, and the mean interval between RCC 
diagnosis and its metastasis to the thyroid gland ranges from 6 to 
12.5 years [2,3,6,8,9]. Although no management guidelines have 
been developed for metastatic RCC in the thyroid gland, many 
reports have asserted that surgical resection of the tumor mass is 
necessary to improve prognostic outcomes with regard to overall 
patient survival [2,7,9-12]. Therefore, the prompt diagnosis of 
metastatic RCC is important for treatment planning. However, few 
reports have addressed the US features specific to metastatic RCC 
in the thyroid gland. Diagnosing thyroid metastasis is challenging 
because metastatic nodules mimic benign masses, and in most 
cases, patients present with no specific symptoms [2-4,9,13]. 
Although fine-needle aspiration (FNA) is commonly used to evaluate 
thyroid nodules, issues regarding false negative or indeterminate 
results specific to metastatic RCC have been increasingly recognized 
[2,9,14,15]. However, no report has focused on metastatic RCC. 
Furthermore, the diagnostic role of core needle biopsy (CNB) specific 
to metastatic RCC in the thyroid has not been investigated. The 
purpose of this study was to present the US features of metastatic 
RCC in the thyroid gland and to evaluate the diagnostic utility of 
FNA and CNB.
Materials and Methods
This retrospective review of images and medical records was 
approved by the Institutional Review Board of our institution, and 
the requirement for informed patient consent was waived. The 
medical database of a single tertiary hospital was reviewed for 
patients with RCC discovered in the thyroid gland from January 
2002 to December 2015. A total of eight patients with nine 
metastatic RCCs in the thyroid gland were included in this study. 
Metastatic RCC was diagnosed by CNB in two nodules and by 
pathologic examination of surgical specimens in seven nodules. 
The surgical specimen served as the reference standard. However, 
when a surgical specimen was not available, the CNB result was 
considered as the final diagnosis and the reference standard. 
The histopathologic subtype of all metastatic RCCs was clear cell 
carcinoma.
US Examination
US examinations were performed by experienced radiologists using 
an ultrasound system with either a 7.5-MHz or 12-MHz linear 
array transducer (HDI 5000 or iU, Phillips-Advanced Technology 
Laboratories, Bothell, WA, USA; Logic 8, GE Medical Systems, 
Milwaukee, WI, USA). Gray-scale and Doppler ultrasonography 
were used to evaluate all thyroid nodules. US examinations were 
performed by one of five board-certified radiologists (4 faculty 
members, 1 fellow) with 1-20 years of experience in thyroid 
imaging. 
Ultrasound-Guided FNA and CNB Procedure
FNA was performed nine times on eight of the nine nodules, and 
CNB was performed six times on six of the nine nodules. US-
FNA was performed using a 23-gauge needle with a combination 
of capillary and aspiration techniques according to guidelines 
suggested by the Korean Society of Thyroid Radiology [16]. US-
FNA was performed by the same radiologists with US, and US-
CNB was done by one radiologist with 20 years of experience. Each 
thyroid nodule was aspirated at least twice, and local anesthesia 
was not routinely applied. The aspirated materials were expelled 
on glass slides, which were immediately placed in 95% alcohol for 
Papanicolaou staining. Immediate cytologic assessment was not 
performed. For nodules larger than 5 cm in size, FNA and CNB were 
performed concurrently. CNB was also performed when the FNA 
cytologic evaluation showed inconclusive results (cell paucity or 
atypia) or when the mass grew in size despite prior benign cytology 
results. CNB was performed with an 18-gauge semi-automated core 
biopsy needle (Stericut biopsy needle, co-axial type, TSK Laboratory, 
Tochigi-Ken, Japan) using the free-hand technique. Local anesthesia 
with 1% lidocaine was applied prior to biopsy procedures. The 
core needle was inserted through the isthmus, via the transisthmic 
approach, positioning the needle tip at the margin of the nodule. 
Two core specimens were routinely obtained for each thyroid nodule. 
After the biopsy, each patient was observed with local compression 
of the biopsy site for 20 minutes. The diagnostic utility based on 
histopathological reports from the FNA and CNB was calculated.
Analysis of Images and Medical Records
All sonograms were retrospectively reviewed by two radiologists 
(1 and 20 years of experiences in consensus). US features were 
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evaluated for characteristics including nodule size, echogenicity, 
taller-than-wide shape, margin, vascularity, the presence of 
calcification, and composition. The risk of malignancy based on US 
features was evaluated using the 2015 American Thyroid Association 
(ATA) management guidelines for adult patients with thyroid 
nodules and differentiated thyroid cancer (2015 ATA guidelines) 
and Korean Thyroid Imaging Reporting and Data System (K-TIRADS) 
[17,18]. 
Based on the 2015 ATA guidelines, a solid hypoechoic nodule 
with at least one suspicious US feature, such as an irregular margin, 
taller-than-wide shape, microcalcifications or rim calcifications, 
or extrathyroidal extension, is categorized as a highly suspicious 
nodule. Intermediate suspicion is assigned to hypoechoic solid 
nodules without the suspicious US features described above. 
Isoechoic or hyperechoic solid nodule without suspicious US 
features are included in the category of low suspicion. Finally, very 
low suspicion is assigned to spongiform or partially cystic nodules 
without suspicious US features. K-TIRADS provides a similar risk 
stratification system, in which a solid hypoechoic nodule with 
any of three suspicious US features (including microcalcifications, 
nonparallel orientation or taller-than-wide shape, and a spiculated/
microlobulated margin) falls into category 5 (high suspicion). Solid 
hypoechoic nodules without any of the three suspicious US features 
or lesions other than hypoechoic solid nodules with any suspicious 
US features are considered category 4 (intermediate suspicion). 
Lesions other than hypoechoic solid nodules without suspicious 
US features are category 3 (low suspicion) or lower. Vascularity is 
classified as absent to equivocal (-, similar to surrounding thyroid 
parenchyma), increased (+, intranodal vascularity <50%), or 
extensive (++, intranodal vascularity >50%) based on the extent 
of vascularity within the tumor mass. Clinical presentation, age at 
diagnosis of metastatic RCC in the thyroid gland, and the interval 
between the initial diagnosis of RCC and thyroid metastasis were 
obtained from patients’ medical records.
Results
Six men and two women made up the study population, and the 
mean age at diagnosis of metastatic RCC in the thyroid gland was 
59.8±9.7 years (range, 49 to 76 years; median, 60.5 years). The 
Table 1. Clinical characteristics and diagnostic results of FNA and CNB in patients with metastatic RCC in the thyroid gland
No.
Age 
(yr)
Sex
Interval 
between RCC 
diagnosis 
and thyroid 
metastasis 
(yr)
Clinical 
presentation
Size
Nodular 
vascularity
Interval 
between 
FNA and 
CNB
Pathologic diagnosis
Prior exam 
(cm)
Interval 
(mo)
Most 
recent (cm)
FNA CNB
Surgical 
specimen
1 76 Male 16 Palpable mass - - 5.0×2.9×5.5 + 0 Benign Metastatic 
RCC
-
2 66 Male 14 Palpable mass 1.5×0.9×1.6 55 2.6×1.7×3.5 ++ 3 wk Nondiagnostic Metastatic 
RCC
Metastatic 
RCC
0.3×0.3×0.5 55 1.4×1.3×2.6 + - - - Metastatic 
RCC
3 59 Female 12 Palpable mass - - 4.3×2.6×5.1 ++ 0 Atypia of 
undetermined 
significance
Metastatic 
RCC
Metastatic 
RCC
4 49 Male 6 Palpable mass 1.0×0.8×1.2 34 1.7×1.4×4.1 ++ 4 wk Benigna),
atypia of 
undetermined 
significancea)
Metastatic 
RCC
-
5 62 Male 4.5 Asymptomatic - - 1.2×0.8×1.5 + 1 wk Nondiagnostic Metastatic 
RCC
Metastatic 
RCC
6 51 Female 4.5 Asymptomatic 2.0×1.0×2.7 13 2.7×1.4×3.2 ++ - Benign - Metastatic 
RCC
7 49 Male 3.5 Palpable mass - - 4.3×2.0×4.9 + - Metastatic 
RCC
- Metastatic 
RCC
8 66 Male 16 Palpable mass 5.8×2.7×7.2 10 5.9×3.3×7.4 ++ 10 mo Benign Metastatic 
RCC
Metastatic 
RCC
Age: age at the time of diagnosis of metastatic RCC in the thyroid gland. Size: size of metastatic nodule at the time of diagnosis.
FNA, fine-needle aspiration; CNB, core needle biopsy; RCC, renal cell carcinoma.
a)FNA was performed twice with a 34-month interval between each FNA.
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mean interval between the surgical resection of RCC and thyroid 
metastasis was 9.6±5.5 years (range, 3.5 to 16 years; median, 9 
years). Six patients presented with a palpable neck mass and two 
patients were asymptomatic at the time of diagnosis (Table 1). The 
maximum diameter of the nodules ranged from 1.5 to 7 cm. Eight 
nodules showed increased fluorodeoxyglucose (FDG) uptake in 
postoperative FDG-positron emission tomography surveillance, and 
ultrasonography was performed for the detection, further evaluation, 
and biopsy of those nodules. Surgical excisions were performed in 
six patients with seven nodules. Bilateral total thyroidectomy was 
performed in one patient (nodules in both lobes), whereas thyroid 
lobectomies were performed in five patients (either right or left 
depending on the side of the nodule). The remaining two patients 
received palliative chemotherapy or radiation therapy due to 
concurrent metastasis to other parts of the body.
US Features
All nine metastatic RCC nodules showed mass formation in the 
thyroid gland, and did not exhibit diffuse thyroid involvement. All 
nodules were oval-shaped, hypoechoic, and solid, and 88.9% (8 of 9) 
showed well-defined smooth margins (Fig. 1). One nodule showed 
an irregular margin. None of the nodules had microcalcifications. 
All nodules showed increased vascularity, and 55% (5 of 9) 
showed extensive vascularity. Lymph node metastasis and direct 
extension to nearby structures beyond the thyroid gland were not 
found. According to the 2015 ATA guidelines, eight nodules were 
A B
C D
Fig. 1. A 59-year-old woman with metastatic thyroid carcinoma (case 3).
A, B. The patient presented with a palpable neck mass that showed increased fluorodeoxyglucose uptake in a positron emission tomography 
scan performed 12 years after renal cell carcinoma was initially diagnosed. Ultrasonography shows (A, transverse; B, color Doppler) a 
4.3×2.6×5.1-cm hypoechoic solid mass with a well-defined smooth margin and extensive vascularity. C. Fine-needle aspiration reveals a 
few round cell clusters showing atypia of undetermined significance/follicular lesion of undetermined significance (Papanicolaou, ×400). D. A 
core needle biopsy shows a solid trabecular tumor with clear cytoplasm (H&E, ×100). 
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moderately suspicious for malignancy and one nodule showed highly 
suspicious US features due to an irregular margin. According to 
K-TIRADS, all nodules showed intermediate suspicion for malignancy 
(K-TIRADS 4).
Four patients had their thyroid nodules evaluated with 
ultrasonography before diagnosis (Table 1). In these cases, initial 
ultrasonography revealed well-defined smooth, oval, or round-
shaped hypoechoic solid nodules with increased vascularity. Follow-
up evaluations performed 10 to 55 months later showed increased 
size for all nodules with similar US features (Fig. 2).
Diagnostic Performance of FNA and CNB
The FNA, CNB, and surgical pathology results are summarized 
in Table 1. FNA was performed nine times in eight nodules, and 
only one FNA (11%) was able to confirm metastatic RCC. In one 
patient (case 4), FNA was performed twice in a single nodule that 
showed benign cytological results despite a high clinical suspicion 
of metastatic malignancy, and subsequent FNA cytology revealed 
atypia of undetermined significance. This nodule was confirmed as 
metastatic RCC by CNB. Overall, FNA yielded the following results: 
nondiagnostic in two lesions (22%), benign in four lesions (44%), 
atypia of undetermined significance in two lesions (22%), and 
metastatic RCC in one lesion (11%). CNB was performed once 
for each of six nodules. All CNBs confirmed metastatic RCC in the 
histopathologic analysis, whereas prior FNA of these six nodules had 
failed to diagnose metastasis. For two nodules, FNA and CNB were 
performed concurrently and the FNA result was benign or atypia of 
undetermined significance, whereas CNB confirmed both nodules as 
metastatic RCC (cases 1 and 3). The CNB specimens showed positive 
immunohistochemical staining using CD10, alpha-methylacyl-CoA 
racemase, vimentin, and RCC marker.
Discussion
Several autopsy series reported in the previous literature have 
shown that the overall incidence of thyroid metastasis ranges from 
1.9% to 24% [1,8]. Although RCC is the most common malignancy 
to metastasize to the thyroid glands, its diagnosis is clinically 
challenging due to its indolent clinical course. Metastatic nodules 
are found long after surgical resection of the primary mass, with 
the mean interval ranging from 6 to 12.5 years, and most patients 
present with no specific symptoms other than a palpable neck mass 
[1-3,6,8]. This is consistent with the characteristic behavior of RCC, 
in which recurrence occurs after a long latency period [10]. In our 
study, the mean interval between the initial RCC diagnosis and 
thyroid metastasis was 9.6±5.5 years, and all patients presented 
with no symptoms other than a palpable neck mass.
The commonly known US features of thyroid metastasis are 
nonspecific findings including nonhomogeneous hypoechogenicity, 
noncircumscribed margins, no calcifications, and increased 
vascularity [1-3]. However, these findings are composed of features 
from various metastatic tumors from different primary malignancies. 
Only a few reports have described findings specific to RCC, which 
include solitary and solid nodules without calcification [14]. 
According to a recently published study, metastatic RCC in the 
thyroid gland tends to form a nodular mass that mimics a primary 
thyroid tumor or even benign masses with few to no suspicious 
US features [6]. In our study, nine metastatic RCC nodules showed 
Fig. 1. E. After a thyroidectomy, a well-demarcated expanding tumor with a fibrous capsule is shown in low magnification (H&E, ×12). F. In 
higher magnification, the tumor shows clear and eosinophilic cytoplasm (H&E, ×200). 
E F
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inaccurate FNA results (28.6%) [2]. In comparison, FNA showed 
high accuracy when used to diagnose other common metastatic 
malignancies, such as breast cancer (94.7%) and lung cancer 
(90.1%) [2]. Clinically significant inaccurate FNA rates specific 
to metastatic RCC have been further observed in other studies 
and case reports, with inaccuracy rates ranging up to 82.3% 
[6,9,14,15,20-22]. The majority of nondiagnostic FNA results were 
reported as benign or indeterminate [6,14,20-22]. On the other 
hand, CNB was able to accurately diagnose metastatic RCC without 
further investigation in most cases [15,23]. 
In our study, only one nodule (11.1%) was confirmed as 
metastatic carcinoma via FNA, whereas all performed CNBs were 
able to correctly diagnose metastatic RCC. This is consistent with 
previous findings in which CNB was found to reduce nondiagnostic 
results, with the diagnostic utility of CNB being superior to that of 
FNA [15,24]. A recent study including 46 metastatic thyroid nodules 
uniform characteristic US features, appearing as hypoechoic solid 
nodules (100%) with well-defined smooth margins (87.5%) and 
increased vascularity (100%). All nodules were classified as high 
or intermediate suspicion according to the ATA guidelines and 
intermediate suspicion on K-TIRADS, which requires FNA of nodules 
≥1 cm. 
FNA is widely accepted as a diagnostic tool for thyroid 
malignancies or metastases, with a reported sensitivity of 73.7%-
94% and specificity up to 100% [8-10,19]. However, the diagnostic 
yield of FNA specific to metastatic RCC needs further investigation, 
as false negative outcomes in FNA cytology have been increasingly 
recognized as a concern for these metastases. Chung et al. [2] 
searched PubMed for articles published between 2000 and 2010 
on metastatic thyroid tumors and reported that preoperative FNA 
performed for thyroid metastases resulted in an incorrect diagnosis 
in 44 of 167 cases (26.3%). Of these, RCC had the highest rate of 
A B
C D
Fig. 2. A 49-year-old man with metastatic renal cell carcinoma (case 4).
A, B. Initial ultrasonography (A, longitudinal; B, color Doppler) shows a 1.0×0.8×1.2-cm hypoechoic solid nodule with a well-defined smooth 
margin and increased vascularity. The initial fine-needle aspiration (FNA) had a result of benign (Bethesda category 2). After 34 months, the 
patient presented with a palpable neck mass. C, D. Follow-up ultrasonography (C, longitudinal; D, color Doppler) reveals an increased nodule 
size (1.7×1.4×4.1 cm) with similar ultrasonographic features. The second FNA had a nondiagnostic result due to the paucity of retrieved 
cells. A subsequent core needle biopsy revealed metastatic renal cell carcinoma.
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from various primary organs showed that all CNBs (n=20) were able 
to confirm the diagnosis without inconclusive or incorrect results 
[15]. CNB has a higher sensitivity and a lower false negative rate 
than FNA, and was less likely to require a further diagnostic work-
up, especially for metastatic thyroid nodules [15].
The cause for this clinically significant rate of inaccurate or 
indeterminate FNA results in metastatic RCC compared to other 
metastatic tumors is not yet known. No study has demonstrated 
the limitations regarding the cytologic evaluation of metastatic 
RCC, and no study has addressed the possibility of renal clear cell 
cytology mimicking benign cytology. However, increased vascularity 
may be the most plausible reason for the low diagnostic yield of 
FNA. Hypervascular nodules are more likely to yield nondiagnostic 
results due to a higher likelihood of blood contamination, which 
makes cytologic examinations more difficult [25]. In addition, 
several intrinsic limitations associated with FNA may reduce 
its diagnostic efficacy in metastatic thyroid nodules. First, only 
cytologic examination is possible with cells retrieved from FNA 
[2]. Immunohistochemical staining with specific antibodies, which 
is often required to diagnose metastatic malignancies in the 
thyroid gland, cannot be performed with FNA specimens [2,6,11]. 
Immunohistochemical markers such as PAX2, RCC marker, CD10, 
vimentin, and alpha-methylacyl-CoA racemase are known to be 
useful in the diagnosis of metastatic RCC [26]. In the context of 
metastasis, FNA usually does not obtain adequate tissue samples for 
these staining techniques [26]. Second, cytologic evaluation alone 
cannot distinguish metastatic high-grade malignancy from primary 
anaplastic carcinoma [15]. Finally, FNA is not able to provide 
diagnostic information on rare primary-origin tumors, such as non-
squamous tumors or non-adenocarcinomas [15]. Histopathologic 
analysis shows a superior diagnostic performance compared to 
cytological analysis, and some authors recommend diagnostic 
surgery to manage thyroid nodules in patients with a history of 
underlying malignancy [2,11]. 
This study has several limitations. First, our study included a 
small number of cases. Nine nodules may not reliably represent 
the US features of metastatic RCC. Furthermore, it is difficult to 
accurately evaluate the diagnostic yields of FNA and CNB based on 
a limited number of cases. Second, not all metastatic nodules were 
histopathologically confirmed with diagnostic surgery. Two of the 
nine nodules were finally diagnosed based on CNB results without 
diagnostic surgery. 
In conclusion, metastatic RCC appears as oval-shaped hypoechoic 
solid nodules with well-defined smooth margins, no calcifications, 
and increased vascularity on ultrasonography. Characteristic US 
features along with a previous history of RCC should raise clinical 
suspicions, and CNB should be performed to make an accurate 
diagnosis.
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